Lakefront Biotherapeutics | GLPG - PE Price to Earnings


Lakefront Biotherapeutics reported 2.68 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
argenx SE 35.53 3.41 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Biogen 23.23 9.53 Jun/2026
Genmab 16.04 1.05 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
GRIFOLS 14.71 3.73 Jun/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Incyte 14.45 0.9 Jun/2026
Merck 17.21 4.47 Jun/2026
Neurocrine Biosciences 22.1 5.99 Jun/2026
Novartis 22.41 2.24 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 18.96 7.12 Jun/2026
UCB 29.7 5.52 Dec/2025
Vertex Pharmaceuticals 28.05 2.22 Jun/2026